The Kenya Union of Clinical Officers, the Ministry of Health and the Council of Governors on Wednesday signed a return-to-work agreement.

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions. Colorized transmission electron micrograph of immature mpox virus particles (blue with red viral envelope) ...

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Welcome to the SIGA Business Update Call. Before we turn the call ...

The pandemic served as a boot camp for Rhode Island public health officials and infectious diseases doctors, preparing them for future health crises ...

There are gaps in the state’s vaccination infrastructure, despite the Bay State’s status as a national leader in medical ...

In eastern Congo, mpox detection and treatment face setbacks amid a rebel offensive backed by Rwanda. Hospitals suffer from ...

In Europe ten people died from measles in 2024, and the US has had several major outbreaks. Bird flu has affected dairy herds ...